1. The Dual Pathway Inhibitor Rigosertib Is Effective in Direct Patient Tumor Xenografts of Head and Neck Squamous Cell Carcinomas
    Ryan T. Anderson et al, 2013, Molecular Cancer Therapeutics CrossRef
  2. Candidate Markers That Associate with Chemotherapy Resistance in Breast Cancer through the Study on Taxotere-Induced Damage to Tumor Microenvironment and Gene Expression Profiling of Carcinoma-Associated Fibroblasts (CAFs)
    Guohua Rong et al, 2013, PLoS ONE CrossRef
  3. Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers
    Ye Xu et al, 2018, Cancer Science CrossRef